DIAGNOSYS LLC

DIAGNOSYS LLC specializes in the design, development, and delivery of precision medical and analytical instrumentation for federal research and clinical applications. The company’s core capabilities center on the engineering of specialized laboratory and surgical devices, including rodent flash electroretinography systems (FERG) for neurophysiological assessment and advanced surgical instrument platforms. Their technical expertise lies in biocompatible materials, low-noise signal acquisition, embedded firmware for real-time data capture, and compliance with FDA-regulated medical device standards. DIAGNOSYS differentiates itself through its focus on high-fidelity diagnostic tools tailored for preclinical and specialized clinical environments, emphasizing reproducibility, calibration stability, and integration with existing biomedical research workflows. The contractor has delivered critical instrumentation to the Department of Veterans Affairs and the Department of Health and Human Services, supporting both veteran healthcare research and broader public health initiatives. For the VA, they have provided neurosensory diagnostic systems used in vision and neurological studies; for HHS, they have supplied surgical instrumentation aligned with NIH-funded biomedical programs. These engagements suggest a pattern of partnership in mission-critical, low-volume, high-specification procurement cycles focused on research-grade devices. Their primary industry focus is in analytical laboratory instrument manufacturing and surgical/medical instrument manufacturing, positioning them as a niche supplier of precision diagnostic and procedural tools rather than mass-market medical devices. They serve the biomedical research and specialized clinical sectors, with an emphasis on devices requiring rigorous environmental control, signal fidelity, and regulatory alignment. DIAGNOSYS LLC is a small business structured as a 2K entity, headquartered in Lowell, Massachusetts. While currently holding no formal government certifications, their geographic proximity to major biomedical research hubs enhances their ability to collaborate with federal science and healthcare programs. Their market positioning reflects a focused, engineering-driven approach to solving complex diagnostic challenges in federal health research environments.